J Biomed Nanotechnol. 2020 May 1;16(5):672-688. doi: 10.1166/jbn.2020.2920.
The lack of neo-cartilage integration with host tissues is a great challenge for the clinical translation of new technologies for the repair of articular cartilage (AC) defect. Recently, we developed a promising double-layered collagen-based system for targeted delivery of fibroblast growth factor 2 (FGF2) to the subchondral bone for AC repair. The system effectively promoted the regeneration of both cartilage and subchondral bone. However, neo-cartilage integration was unsatisfactory, which might be due to the presence of a zone of cell death (ZCD) in the cartilage induced by injury. Here, we hypothesized that maintaining cell viability in the region surrounding the defect and decreasing the size of ZCD by using chondroprotective agents such as insulin-like growth factor-1 (IGF-1), might be an effective strategy to improve neo-cartilage integration. A targeted delivery system for IGF-1 to cartilage based on the FGF2 delivery system was formulated to weaken the impact on the effects of FGF2. The two growth factors were incorporated into the different layers of the membrane without interdiffusion. Due to the different densities of collagen fibers in the different layers, the and assays demonstrated that both proteins were released via unidirectional diffusion without mixing or lateral diffusion. Particularly, the released IGF-1 increased the viability of chondrocytes, decreased the ZCD size, and enhanced the integration of regenerative neo-cartilage with host tissues, without any undesirable effects on the FGF2mediated regeneration of cartilage and subchondral bone. Taken together, our findings demonstrate that the collagen fiber membrane-aided chondroprotective-based strategy is an effective way to improve neo-cartilage integration.
新软骨与宿主组织的整合不良是关节软骨(AC)缺损修复新技术临床转化的一大挑战。最近,我们开发了一种有前途的双层胶原基系统,用于将成纤维细胞生长因子 2(FGF2)靶向递送至软骨下骨以修复 AC。该系统有效地促进了软骨和软骨下骨的再生。然而,新软骨的整合并不令人满意,这可能是由于损伤诱导的软骨中存在细胞死亡区(ZCD)。在这里,我们假设通过使用胰岛素样生长因子 1(IGF-1)等软骨保护剂来维持缺损周围区域的细胞活力并减小 ZCD 的大小,可能是改善新软骨整合的有效策略。基于 FGF2 递送系统,我们构建了一种针对软骨的 IGF-1 靶向递送系统,以减弱对 FGF2 效果的影响。两种生长因子被纳入膜的不同层而不互扩散。由于不同层中的胶原纤维密度不同,和 测定表明,两种蛋白质均通过单向扩散释放,而不会混合或侧向扩散。特别是,释放的 IGF-1 增加了软骨细胞的活力,减小了 ZCD 的大小,并增强了再生新软骨与宿主组织的整合,而对 FGF2 介导的软骨和软骨下骨再生没有任何不良影响。总之,我们的研究结果表明,胶原纤维膜辅助的基于软骨保护的策略是改善新软骨整合的有效方法。